Timing of outcome measurements
Baseline | Post randomisation (months) | |||||||
1 | 3 | 4 | 6 | 12 | 18 | 24 | ||
Clinical | ||||||||
Medical history | x | |||||||
Humphrey visual field mean deviation | x | x | x | x | ||||
Esterman Visual Field | x | x | ||||||
LogMAR visual acuity | x | x | x | x | ||||
Intraocular pressure | x | x | x | x | ||||
Standard clinical examination | x | x | x | |||||
Patient experience | ||||||||
NEI-VFQ-25 | x | x | x | x | ||||
EQ-5D-5L* | x | x | x | x | x | x | x | |
HUI-3* | x | x | x | x | x | x | x | |
GUI* | x | x | x | x | x | x | x | |
Patient experience questions | x | x | x | x | x | x | x | |
Health economics | ||||||||
Healthcare utilisation (including hospital visits) | x | x | x | |||||
Participant cost | x | x | x | |||||
Participant time and travel | x |
*Additional questionnaire undertaken immediately prior to trabeculectomy surgery; discrete choice experiment at 27 months;
GUI, Glaucoma Utility Index; HUI-3, Health Utility Index; LogMAR, logarithm of the mean angle of resolution; NEI-VFQ25, National Eye Institute Visual Function Questionnaire (25 items).